Back to search
FDAFDA · Food and drugs·Recall number Z-0762-2023

Revaclear 300 dialyzers. Indicated for treatment of chronic and acute renal failure by hemodialysis.

Published December 28, 2022 · Recall initiated: November 23, 2022

Summary

FDA records medical device Class II recall Z-0762-2023, published December 28, 2022 and initiated November 23, 2022. Recalling firm: Baxter Healthcare Corporation; Status: Ongoing; Reported quantity: 14,053,824 units; Lot: UDI-DI: 07332414123055; Product Code: 114745L; All lot numbers from C419128801-C422128401. Class II means possible temporary or medically reversible effects, or a remote probability of serious health consequences.

Status when published: Ongoing — openFDA updates weekly, so this field may not reflect the current status. Always confirm with the official notice.

What's the hazard

Reports of Polyurethane Displacement in the dialyzer, and might be identified as a blood leak

What to do

Voluntary: Firm initiated · Letter

Get an email when a new FDA recall like this is published

Free. We only write when there's a new recall that matches. Unsubscribe in one click.

Recall details

Manufacturer
Baxter Healthcare Corporation
Distributor
Worldwide distribution - US Nationwide and the countries of Canada, China, Australia, New Zealand, Austria, Egypt, France, Germany, Ireland, Italy, Morocco, Qatar, Saudi Arabia, South Africa, Spain, United Kingdom, Bahamas, Barbados, Belize, Bermuda, Colombia, Dominican Republic, Ecuador, Guatemala, Honduras, Mexico, Panama, St. Thomas, Trinidad and Tobago.
Lot
UDI-DI: 07332414123055; Product Code: 114745L; All lot numbers from C419128801-C422128401
Risk classification
Class II
Area (FDA)
device
Country
United States

Related recalls

Questions about this recall

Was Revaclear 300 dialyzers. Indicated for treatment of chronic and acute renal failure by hemodialysis. recalled?

Yes. FDA published recall Z-0762-2023 on December 28, 2022. Reported hazard: Reports of Polyurethane Displacement in the dialyzer, and might be identified as a blood leak

What should I do if I have this product?

Voluntary: Firm initiated · Letter